https://doi.org/10.1074/mcp.m116.066506
A
Aviv Pudipeddi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
311
Citations
10
h-index
10
i10-index
Aviv Pudipeddi is an academic researcher from The University of Sydney. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Liver Diseases and Immunity. The author has an h-index of 10, co-authored 63 publications.
ORCID: 0000-0002-3664-2246Papers by this author
worksSerological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease
2017 · Molecular & Cellular Proteomics · 17 citations
Vedolizumab serum trough concentrations with and without thiopurines in ulcerative colitis: The prospective VIEWS pharmacokinetics study
2024 · World Journal of Gastroenterology · 2 citations
https://doi.org/10.3748/wjg.v31.i2.101292
Mo1846 DEVELOPMENT OF SIMPLIFIED SCORING SYSTEM TO PREDICT TWO-YEAR CLINICAL REMISSION OF PATIENTS WITH ULCERATIVE COLITIS AFTER TREATMENT WITH VEDOLIZUMAB
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)03085-3
Su1760 CLINICAL AND ENDOSCOPIC REMISSION AT 3 MONTHS AFTER ACUTE SEVERE ULCERATIVE COLITIS IS PREDICTIVE OF MAINTENANCE THERAPY OUTCOMES AT 12 MONTHS - RESULTS FROM PREDICT UC
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)02324-2
Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn’s disease: rationale, design and protocol for the randomised controlled VECTORS trial
2026 · BMJ Open Gastroenterology · 0 citations
https://doi.org/10.1136/bmjgast-2025-002088
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat